By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
DelMar Pharma Release: FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer 4/21/2016 6:22:28 AM
DelMar Pharma Updates Ongoing Phase I/II Refractory GBM Clinical Trial With VAL-083 At AACR Annual Meeting 4/19/2016 11:05:43 AM
DelMar Pharma's VAL-083 Demonstrates Promise In The Treatment Of Non-Small Cell Lung Cancer And Ovarian Cancer 4/19/2016 10:01:58 AM
DelMar Pharma Announces New Data Supporting The Unique Anti-Cancer Mechanism Of VAL-083 4/19/2016 7:22:43 AM
DelMar Pharma's VAL-083 Demonstrates Promise In The Treatment Of Non-Small Cell Lung Cancer And Ovarian Cancer 4/18/2016 8:06:20 AM
DelMar Pharma Announces Abstract Presentations For The AACR Annual Meeting In April 2016 3/24/2016 7:25:01 AM
DelMar Pharma Release: FDA Grants Second Orphan Designation For VAL-083 3/15/2016 6:46:56 AM
DelMar Pharma Announces Second Quarter Fiscal Year 2016 Financial Results And Corporate Update 2/16/2016 10:24:05 AM
DelMar Pharma To Present At The 18th Annual BIO CEO & Investor Conference On February 8, 2016 2/4/2016 8:14:02 AM
DelMar Pharma To Collaborate With MD Anderson Cancer Center On Development Of DelMar's VAL-083 In Brain Cancer 1/14/2016 11:08:41 AM
12345678910...
//-->